
BioPhorum 2020 highlights

Aiming high with a User Requirements Specification for CCIT

How to do environmental monitoring to an industry standard

Has the pandemic ushered in an era of virtual inspections and audits?

BioPhorum celebrates its 200th membership

How industry is using technology during the COVID-19 pandemic

PUPSIT: identifying risks and preventive controls

A clear path to implementing alternative and rapid microbiological methods

How to solve the CCI puzzle

How is industry responding to the covid-19 pandemic?

Interested in being a BioPhorum peer reviewer?

How to learn about PUPSIT in terminal sterilizing filtration – the science, implications and implementation

Removing human intervention in aseptic filling: Realizing the full potential of seamless integration of robotics in filling operations

BioPhorum contributes to the US Congressional drug wastage debate

Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies

Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China

MedTech considers drug device challenges

BioPhorum accelerates growth

As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?

Lending a hand – BioPhorum’s new glove management guidance

PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position

Driving the evolution of secondary packaging

Changing mindsets with a modular approach

The Fill Finish Phorum – tackling issues around the operation of isolators

PUPSIT consortium name converted to SFQRM

Providing clarity when classifying visible particles

VI Risk Classification Tool PoC September 2018

Lyophyilization: commercial scaling modelling

Companies encouraged to adopt more appropriate measures of stopper particle contamination
